4
Changes in Ownership
Apimeds Pharmaceuticals US, Inc. Filed Acc 0002040022-25-000002
Options or other derivatives
- Chairman and CMO acquired 3,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kim Christopher Chairman and CMO | 2025-10-15 | Grant or award · Stock Option (right to buy) | +3,000 | 3,000 | D | ||
Loading xslF345X05/primary_doc.xml…